Australia splits cosmetic oversight across three agencies, and the short answer for a skincare brand is this: register your ingredient introductions with AICIS before you import or manufacture, confirm whether each product sits on the TGA side of the line (a primary sunscreen or a melanin-inhibiting brightening product does), and build labels and claims that survive ACCC scrutiny under the Australian Consumer Law. The sequence matters as much as the content — product classification first, registration and documentation next, artwork and claims last — because each step feeds the next, and reprinting a label costs far more than revising a classification.
This guide breaks down who regulates what, what each agency actually asks of you, and a practical order of operations. It complements our market-entry guides for the US under MoCRA, Southeast Asia, Japan and Latin America, for brands planning multi-market launches.
How is cosmetic regulation split between AICIS, TGA and ACCC?
Three agencies divide the work, and each one answers a different question:
| Agency | What it governs | What it asks of you |
|---|---|---|
| AICIS | Industrial chemicals — including cosmetic ingredients — under the Industrial Chemicals Act 2019 | Register the introduction before importing or manufacturing, classify each introduced chemical, file an annual declaration |
| TGA | Therapeutic goods, a category that includes primary sunscreens, products that inhibit melanin production and disinfectants | List the product on the ARTG (Australian Register of Therapeutic Goods) when it is regulated as a therapeutic good |
| ACCC | Labels, safety and claims under the Australian Consumer Law | Labels and claims must not mislead; follow the Consumer Goods (Cosmetics) Information Standard 2020 |
Nothing in this split is unique to imported brands — domestic manufacturers face the same AICIS introduction obligations. What differs for an overseas brand is timing: the registration step lands before your first shipment, not after you have tested the market.
How does AICIS registration and ingredient classification work?
In Australia, cosmetic ingredients are regulated as industrial chemicals. If you import or manufacture a cosmetic, you are also introducing industrial chemicals, and AICIS requires that introduction to be registered before it happens. There is no monetary threshold: a first small order triggers the same obligation as a full-scale import program.
Registration works at the level of the introduced chemical, not the finished product, so ingredient-level homework comes first. Each introduced chemical falls into one of several categories:
- Listed — already on the AICIS Inventory, the lowest-friction path.
- Exempted — covered by an exemption from registration or reporting.
- Reported — the introduction is reported to AICIS, with detail requirements varying by category.
- Assessed — the introduction requires an assessment certificate before it proceeds.
- Commercial Evaluation — chemicals authorized for a specific commercial use.
After registration, introducers file an annual declaration. For a brand owner, the practical consequence is scheduling: the AICIS step sits on the critical path of your first import, so the ingredient review should start while the formula is still open to change — not after production is booked. If a novel or higher-risk ingredient appears late in development, it can move your launch date more than any packaging decision.
Which products fall under TGA — and why do sunscreens and brightening products matter?
TGA regulates therapeutic goods, and several everyday skincare categories sit on that side of the line. A primary sunscreen — a product presented mainly for sun protection — is regulated as a therapeutic good, which means listing on the ARTG. The same applies to products presented as inhibiting melanin production, the brightening and whitening category, and to disinfectants.
There is an important carve-out for secondary sunscreens. Cosmetics that carry an SPF but are presented primarily as moisturizers or other leave-on cosmetics can be excluded goods under the Therapeutic Goods (Excluded Goods) Determination 2018 — meaning they do not need ARTG listing. But the classification is product-specific, decided on how the product is presented and its primary purpose. A moisturizer with SPF 30 marketed mainly for hydration and a serum marketed mainly for brightening can land on opposite sides of the same line.
For formulation and claims planning, the takeaway is blunt: claims pull products across the regulatory line. If marketing wants language about lightening pigment or inhibiting melanin, expect the TGA conversation to happen early — not after artwork is signed off.
What are the ACCC’s bottom lines for labels and claims?
Labels and claims are policed by the ACCC under the Australian Consumer Law, and the governing test is whether the presentation is misleading — to consumers, and in context. The Consumer Goods (Cosmetics) Information Standard 2020 sets out the mandatory label elements for cosmetics sold in Australia, including an ingredient list in English.

Two practical rules follow. First, a claim that is acceptable in another market may still be misleading here if the Australian context gives it a different reading — market-specific expectations matter, and identical wording can carry different weight. Second, unsupported claims are the exposure: a statement a brand cannot substantiate is at risk even if no competitor complains, because the standard is consumer perception, not intent.
Working with a manufacturer that has shipped into Australia before helps here. Ingredient names, INCI formatting and warning statements that have passed Australian review are faster to approve than a fresh translation of artwork built for another market.
What does the Poisons Standard mean for ingredient limits?
Ingredient limits in Australia reference the Poisons Standard (SUSMP, the Standard for the Uniform Scheduling of Medicines and Poisons). Schedules assign control levels — who may supply the substance, in what concentration, with what warning statements and label conditions.
For a brand owner, this is a formula-review exercise rather than a paperwork exercise. The full composition — UV filters, preservatives, actives, even functional trace ingredients — should be checked against current scheduling before the formula is locked, because a scheduling limit can force a reformulation late in the project. It also interacts with the TGA question: restricted-use ingredients can reinforce the case that a product belongs on the therapeutic side.
What is a practical entry sequence, and where do brands trip up?
A workable order of operations looks like this:
- Classify first. Decide whether each SKU is a cosmetic, a primary sunscreen, or a therapeutic-side product — brightening claims push it in that direction.
- Review ingredients and start AICIS registration before the first import, while the formula is still open.
- Check the formula against the Poisons Standard and settle any reformulation before sampling rounds.
- Design artwork against the Information Standard 2020 — English ingredient list, mandatory elements — and pressure-test every claim against the misleading-conduct test.
- Only then book production and shipping, with the ARTG question already answered for any therapeutic-side SKU.
Where launches stumble is usually predictable. The most common trip-up is assuming a moisturizer with SPF is automatically exempt — the exemption is real, but the classification is product-specific and presentation matters. The second is claims: a brightening claim that reads as melanin inhibition quietly moves a cosmetic into TGA territory, and fixing that after artwork means reprinting. The third is documentation drift — an ingredient list that was acceptable in another market but is not in English, or missing mandatory label elements. None of these are exotic problems; they are sequencing problems, and they are cheaper to solve before the first purchase order than after.
For brands already exporting to the US, Japan, Southeast Asia or Latin America, the Australian file works more smoothly when it is planned alongside those programs rather than in isolation — ingredient classification work and claim substantiation files transfer in substance, even where the regulators and lists do not. Requirements still vary by market and product type, so each launch needs its own confirmation pass.
If you are planning an Australian launch and want the regulatory sequence reflected in your development plan, CHONGSHENG FUTURE(重生未来)supports brand owners with formulation development, ingredient documentation, claims review support and production planning for multi-market programs. Share your target formats, ingredient preferences and target markets with our team, and we can map the development sequence — including the AICIS and TGA checkpoints — before sampling begins.